Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Assertio Holdings Inc (ASRT)  
$0.96 0.09 (8.57%) as of 4:30 Fri 5/10


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 94,670,000
Market Cap: 90.88(M)
Last Volume: 940,193 Avg Vol: 714,677
52 Week Range: $0.754 - $7.66
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Assertio Therapeutics is a pharmaceutical company. Co.'s primary marketed products include: INDOCIN® (indomethacin) Suppositories and INDOCIN® (indomethacin) Oral Suspension, which is a suppository form and oral solution of indomethacin, a nonsteroidal anti-inflammatory drug (NSAID), approved for moderate to severe rheumatoid arthritis, ankylosing spondylitis and osteoarthritis; CAMBIA® (diclofenac potassium for oral solution), which is a prescription NSAID indicated for the acute treatment of migraine attacks in adults; and Otrexup® (methotrexate) injection, used to treat adults with severe, active rheumatoid arthritis, and children with active polyarticular juvenile idiopathic arthritis.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 165
  Page 5 of 7  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Dawes Karen A Director   –       •      –    2016-05-12 4 D $17.52 $12,860 D/D (734) 12,867     -
   Staple Peter D Director   –       •      –    2016-05-12 4 D $17.52 $18,133 D/D (1,035) 84,403     -
   Anido Vicente Jr Director   –       •      –    2016-05-12 4 D $17.52 $18,133 D/D (1,035) 4,403     -
   Zenoff David B Director   –       •      –    2016-05-12 4 D $17.52 $18,133 D/D (1,035) 23,999     -
   Saks Samuel R Director   –       •      –    2016-05-12 4 D $17.52 $12,860 D/D (734) 5,099     -
   Lavigne Louis J Jr Director   –       •      –    2016-05-12 4 D $17.52 $18,133 D/D (1,035) 4,403     -
   Vargas Thadd M Senior VP, BD   •       –      –    2016-05-10 4 AS $17.64 $264,600 D/D (15,000) 124,297     -
   Moretti August J Chief Financial Officer & SVP   •       –      –    2016-05-09 4 AS $18.00 $90,000 D/D (5,000) 22,879     -
   Shively Richard Scott SVP & Chief Commercial Officer   •       –      –    2016-04-02 4 D $14.38 $13,517 D/D (940) 4,290     -
   Gosling Matthew M SVP, General Counsel   •       –      –    2016-04-02 4 D $14.38 $13,517 D/D (940) 55,236     -
   Moretti August J Chief Financial Officer & SVP   •       –      –    2016-04-02 4 D $14.38 $13,517 D/D (940) 27,879     -
   Srinivas Rao SVP and Chief Medical Officer   •       –      –    2016-04-02 4 D $14.38 $13,517 D/D (940) 8,469     -
   Vargas Thadd M Senior VP, BD   •       –      –    2016-04-02 4 D $14.38 $13,517 D/D (940) 139,297     -
   Schoeneck James A President and CEO   •       •      –    2016-03-18 4 OE $3.38 $120,094 D/D 30,483 36,848     -
   Vargas Thadd M Senior VP, BD   •       –      –    2016-03-11 4 S $16.00 $368,000 D/D (23,000) 137,737     -
   Srinivas Rao SVP and Chief Medical Officer   •       –      –    2016-03-08 4 OE $11.83 $29,989 D/D 2,535 6,909     -
   Vargas Thadd M SVP, Business Development   •       –      –    2016-03-02 4 S $15.18 $151,780 D/D (10,000) 160,737     -
   Vargas Thadd M SVP, Business Development   •       –      –    2016-01-11 4 OE $7.12 $129,442 D/D 18,180 170,737     -
   Schoeneck James A President and CEO   •       •      –    2015-12-28 4 OE $6.11 $38,890 D/D 6,365 6,365     -
   Moretti August J Chief Financial Officer & SVP   •       –      –    2015-12-16 4 OE $5.35 $26,750 D/D 5,000 26,319     -
   Schoeneck James A President and CEO   •       •      –    2015-12-14 4 GA $0.00 $0 I/I 51,847 398,735     -
   Schoeneck James A President and CEO   •       •      –    2015-12-14 4 GD $0.00 $0 D/D 51,847 0     -
   Moretti August J Chief Financial Officer & SVP   •       –      –    2015-12-03 4 AS $18.01 $271,597 D/D (15,000) 21,319     -
   Moretti August J Chief Financial Officer & SVP   •       –      –    2015-12-01 4 D $19.00 $139,251 D/D (7,329) 36,319     -
   Lavigne Louis J Jr Director   –       •      –    2015-12-01 4 D $19.00 $25,859 D/D (1,361) 2,502     -
  165 Records found
  1  2  3  4  5  6  7   
  Page 5 of 7
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us